BRKR Stock Risk & Deep Value Analysis

Bruker Corp

Healthcare • Medical Devices

DVR Score

0.5

out of 10

Distressed

The Bottom Line on BRKR

We analyzed Bruker Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran BRKR through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 23, 2026•Run Fresh Analysis →

📈BRKR Performance Overview3yr weekly

📊

Unlock BRKR Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

BRKR Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Medium

Market Risk

High

About Bruker Corp (BRKR)

Sector

Healthcare

Industry

Medical Devices

Market Cap Category

mid

Market Cap

$5.07B

BRKR Deep Value Analysis

Bruker Corp. remains a high-quality, innovative leader in specialized scientific instruments with a strong competitive moat, primarily in areas like NMR and Mass Spectrometry. Its financial health, including a healthy balance sheet (current ratio 1.73, D/E 0.75) and positive Q4 FCF ($207M), suggests stability. However, Q4 2025 results showed flat revenue (-0.2% YoY), a significant 5.1% organic decline, and an EPS miss ($0.59 vs. $0.65 estimate). Operating margins are declining (15.7%, down 240 bps YoY), and full-year operating cash flow was negative. Management's FY26 guidance projects only 4-5% revenue growth. The company is implementing a cost savings program, indicating a focus on efficiency rather than aggressive expansion. These factors, alongside persistent weak demand in key segments and recent analyst downgrades, confirm that BRKR is a stable, mature compounder navigating cyclical headwinds. There are no clear, identifiable catalysts or a strategic pivot that suggest 10x growth potential within 3-5 years, consistent with its previous assessment. The score of 5/100 reflects this lack of hyper-growth potential, not a judgment on its quality as a company.

BRKR Red Flags & Warning Signs

Premium

⚠
Further weakening of global demand in key customer segments
⚠
Escalation of tariffs or trade tensions impacting supply chain and sales
⚠
Continued decline in NIH budgets affecting research funding
⚠
Intensified competitive pressure or disruptive technology from rivals

Unlock BRKR Red Flags & Risk Warnings

Premium members see every risk event we found.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

BRKR Financial Health Metrics

Market Cap

$5.07B

P/E Ratio

-222.17

Profit Margin

-0.25%

Debt-to-Equity

0.75

Dividend Yield

0.60%

Beta (Volatility)

1.19

Earnings Per Share

$0.59

BRKR Competitive Moat Analysis

Premium

Moat Rating

Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Intangible Assets/IPSwitching CostsEfficient Scale

Bruker's moat is durable due to its specialized intellectual property in high-precision scientific instruments, which are expensive and complex to develop and replace, leading to high switching costs for established customers. The company also benefits from efficient scale in its niche markets.

BRKR Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

BRKR Catalysts & Growth Drivers

Near-Term (0-6 months)

•Q1 2026 Earnings Report (May 6, 2026)
•Impact of $100M+ cost savings program on 2026 margins

Medium-Term (6-18 months)

•Potential recovery in academic, government, and biopharma spending post-2026
•Stabilization of demand in the China market

Long-Term (18+ months)

•Continued innovation in highly specialized scientific instruments (e.g., advanced NMR, Mass Spec)
•Leveraging installed base for recurring revenue and service contracts

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

BRKR Bull Case: What Could Go Right

✓
Consistent reacceleration of organic revenue growth across all segments (especially above 5%)
✓
Demonstrable expansion in non-GAAP operating margins driven by efficiency and favorable mix
✓
Positive revisions to full-year guidance and improvement in book-to-bill ratios

Bull Case Analysis

See what could go right with Premium

🔔

Never miss a move on BRKR

Create a free account to set price alerts and get notified on Telegram when BRKR hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for Bruker Corp (BRKR)?

As of March 23, 2026, Bruker Corp has a DVR Score of 0.5 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Bruker Corp?

Bruker Corp's market capitalization is approximately $5.1B. The company operates in the Healthcare sector within the Medical Devices industry.

What ticker symbol does Bruker Corp use?

BRKR is the ticker symbol for Bruker Corp. The company trades on the NMS.

What is the risk level for BRKR stock?

Our analysis rates Bruker Corp's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of BRKR?

Bruker Corp currently has a price-to-earnings (P/E) ratio of -222.2. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

Does Bruker Corp pay a dividend?

Yes, Bruker Corp pays a dividend with a current yield of approximately 0.60%.

Is Bruker Corp's revenue growing?

Bruker Corp has reported revenue growth of -0.2%. Revenue has been declining, which warrants closer examination.

Is BRKR stock profitable?

Bruker Corp has a profit margin of -0.3%. The company is currently unprofitable.

How often is the BRKR DVR analysis updated?

Our AI-powered analysis of Bruker Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 23, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.